S 2866 117th Congress Senate Health Cardiovascular and respiratory health Drug therapy Emergency medical services and trauma care Health care coverage and access Health facilities and institutions Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases State and local government operations

TREAT Act

Introduced: September 28, 2021 See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 28, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sep 28, 2021

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Treatment Restoration for Emergency Antibody Therapeutics Act or the TREAT Act

This bill prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In addition, the bill expressly nullifies a policy announced on September 13, 2021, under which HHS allocated supplies of these therapies through state or territorial governments.

What's happening now September 28, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Related & companion bills 1

Bill text 1 version